Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study

Overview of attention for article published in Frontiers in immunology, November 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 32,706 followers.

New Research: Transarterial chemoembolization combined donafenib with/without PD-1 for unresectable HCC in a multicenter retrospective study: Background & aims This multicenter retrospective study evaluated the efficacy and safety of… https://t.co/PeQ

28 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.